Washington, D.C. – May 21, 2007 -- A new study demonstrated that the active ingredient in AMITIZA® (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with ...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc., announced today that AMITIZA (lubiprostone), 24-mcg soft-gel capsules, approved by the US Food and Drug Administration ...

Lubiprostone Medication Information. Learn everything you need to know about Lubiprostone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

Sucampo Pharmaceuticals' (NASDAQ:SCMP) Lubiprostone treatment was effective and well tolerated in a trial of 127 of children and adolescents with functional constipation. "The results of this ...

Moeser et al. Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine.

September 26, 2012 (Phoenix, Arizona) — Constipation drug lubiprostone (Amitiza, Sucampo Pharmaceuticals, Takeda Pharmaceuticals) shows efficacy and tolerability in treating opioid-induced ...

The first authorized generic version of Amitiza (lubiprostone; Mallinckrodt) has been made available by Par Pharmaceutical, Inc.. Lubiprostone, a chloride channel activator, is indicated for the ...

Sucampo announced positive top-line results from an open-label Phase 3 clinical trial designed to evaluate the long-term safety and efficacy of lubiprostone in opioid-induced bowel dysfunction ...

In February 2009, Sucampo entered into a license, commercialization, and supply agreement for lubiprostone with Abbott Japan Co. Ltd. under which Abbott received exclusive rights to commercialize ...

The FDA has expanded the indication for oral lubiprostone (Amitiza) to include opioid-induced constipation in chronic, non-cancer pain patients, according to a statement from the drug’s ...

In February 2009, Sucampo entered into a license, commercialization, and supply agreement for lubiprostone with Abbott Japan Co. Ltd. under which Abbott received exclusive rights to commercialize ...